Drug Profile
Interferon omega
Alternative Names: IFN-omega; Interferon-omega; ITCA-638; Omega DUROS interferon therapy; Omega-interferonLatest Information Update: 11 Aug 2015
Price :
$50
*
At a glance
- Originator Boehringer Ingelheim
- Developer Boehringer Ingelheim; Intarcia Therapeutics
- Class Antivirals; Interferons
- Mechanism of Action Immunostimulants; Interferon type I stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cancer; Hepatitis C
Most Recent Events
- 16 Apr 2007 Final results from a phase II clinical trial in patients with hepatitis C added to the adverse events and Viral Infections therapeutic trials sections
- 10 Jun 2005 Data presented at the 18th International Conference on Antiviral Research (ICAR-2005) have been added to the Adverse Events and Viral Infections antimicrobial activity sections
- 30 Nov 2004 Phase-II clinical trials in Hepatitis C in Russia (SC)